Skip to main content

SAVE THE DATE FOR OUR CLL IRELAND PATIENT & CARER INFORMATION DAY ON OCTOBER 5TH!

 

Welcome to CLL Ireland

A Patient Advocacy Group

Cll Ireland Is a Patient-Led Advocacy Group.

Our goal, is to ensure that anyone affected by Chronic Lymphocytic Leukaemia (CLL) can gain access to the information, advice and support they need when they need it!

Important Information

Living with CLL

Learn more about CLL

Treatment

What type of treatments are available?

Support

Getting support to make the difference

Community & Research

Learn more about what's happening in the CLL Community

FAQ’s

We try to answer your most common questions

Latest News

Ireland needs similar action👇
Australia’s Blood Cancer Taskforce has today released five new “optimal care pathways” (OCPs) aimed at improving treatment consistency and reducing avoidable deaths from blood cancer.
@DonnellyStephen
https://www.petermac.org/about-us/news-and-events/news/details/new-guides-to-reduce-avoidable-deaths-from-blood-cancer

Load More
Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
4 hours ago
CLL Ireland

#EHA2024 Frontline therapy for #CLL , @NitinJainMD presents results phase 2 trial of Pirtobrutinib, Venetoclax and Obinutuzumab as a first line treatment.
Very positive results from this time limited treatment.
85% of patients had no detectable disease U-MRD in BM after 12 months
... See MoreSee Less

#EHA2024 Frontline therapy for #CLL , @NitinJainMD presents results phase 2 trial of Pirtobrutinib, Venetoclax and Obinutuzumab as a first line treatment.
Very positive results from this time limited treatment.
85% of patients had no detectable disease U-MRD in BM after 12 monthsImage attachmentImage attachment+2Image attachment
4 hours ago
CLL Ireland

CLL Ireland is delighted to be here at the EHA conference to represent our patient community.

Update on Ricters Transformation.

Professor Arnon Kater #EHA2024 on using single agent Epcoritamab to treat patients whose #CLL has transformed to Ricters.
EPCORE CLL-1 trial show this treatment leads to deep responses.

Full House for this CLL sessions.
... See MoreSee Less

CLL Ireland is delighted to be here at the EHA conference to represent our patient community.
Update on Ricters Transformation.
Professor Arnon Kater #EHA2024 on using single agent Epcoritamab to treat  patients whose #CLL has transformed to Ricters.
EPCORE CLL-1 trial show this treatment leads to deep responses.
Full House for this CLL sessions.Image attachmentImage attachment+2Image attachment
Load more

Ireland needs similar action👇
Australia’s Blood Cancer Taskforce has today released five new “optimal care pathways” (OCPs) aimed at improving treatment consistency and reducing avoidable deaths from blood cancer.
@DonnellyStephen
https://www.petermac.org/about-us/news-and-events/news/details/new-guides-to-reduce-avoidable-deaths-from-blood-cancer

Load More

Looking for more information about CLL?

We’ve produced a handy booklet explaining all about CLL. We cover such topics as:

  • What is CLL?
  • Signs & Symptoms of CLL
  • Staging
  • Treating CLL
  • Complications of CLL
  • Living with CLL
  • Talking about CLL

and much more! Click on the button below to open the file – it’s a great resource and we’re delighted to share it with you!

Click Here For CLL Booklet!

Get in touch with

CLL Ireland today

Click Here

Information about CLL

We’ve put together a set of resources to help you on your journey with CLL. Click to find out more!

Donate Now

Support our services and help us to continue our advocacy work. Your donation will help make a difference.

Skip to content